TITLE 18. PROFESSIONAL AND OCCUPATIONAL LICENSING
REGISTRAR'S NOTICE: The
Board of Pharmacy is claiming an exemption from Article 2 of the Administrative
Process Act in accordance with § 2.2-4006 A 13 of the Code of Virginia,
which exempts amendments to regulations of the board to schedule a substance in
Schedule I or II pursuant to subsection D of § 54.1-3443 of the Code of
Virginia. The board will receive, consider, and respond to petitions by any
interested person at any time with respect to reconsideration or revision.
Title of Regulation: 18VAC110-20. Regulations Governing
the Practice of Pharmacy (amending 18VAC110-20-322).
Statutory Authority: §§ 54.1-2400 and 54.1-3443 of the
Code of Virginia.
Effective Date: November 16, 2016.
Agency Contact: Caroline Juran, RPh, Executive Director,
Board of Pharmacy, 9960 Mayland Drive, Suite 300, Richmond, VA 23233-1463,
telephone (804) 367-4416, FAX (804) 527-4472, or email
caroline.juran@dhp.virginia.gov.
Summary:
As specified in § 54.1-3443 of the Code of Virginia, the
amendments place five compounds into Schedule I of the Drug Control Act. The
placement by regulatory action will remain in effect for 18 months or until the
compounds are placed in Schedule I by legislative action of the General
Assembly.
18VAC110-20-322. Placement of chemicals in Schedule I.
A. Pursuant to subsection D of § 54.1-3443 of the Code of
Virginia, the Board of Pharmacy places the following in Schedule I of the Drug
Control Act:
1. N-phenyl-N-[1-(2-phenylethyl)-4-piperidinyl]-butanamide
(other name: butyryl fentanyl).
2. Flubromazolam.
3. 5-methoxy-N,N-methylisopropyltryptamine (Other name:
5-MeO-MIPT).
4. Cannabimimetic agents:
a. N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1-[(4-fluorophenyl)methyl]-1H-indazole-3-carboxamide
(other name: ADB-FUBINACA);
b. Methyl 2-[1-[(4-fluorophenyl)methyl]-1H-indazole-3-carboxamido]-3,3-dimethylbutanoate
(other name: MDMB-FUBINACA); and
c. Methyl 2-[1-(5-fluoropentyl)-1H-indazole-3-carboxamido]-3,3-dimethylbutanoate
(other names: 5-fluoro-ADB, 5-Fluoro-MDMB-PINACA).
The placement of drugs listed in this subsection shall remain
in effect until December 14, 2017, unless enacted into law in the Drug Control
Act.
B. Pursuant to subsection D of § 54.1-3443 of the Code of
Virginia, the Board of Pharmacy places the following in Schedule I of the Drug
Control Act:
1. Beta-keto-N,N-dimethylbenzodioxolylbutanamine (other names:
Dibutylone, bk-DMBDB);
2. 1-(1,3-benzodioxol-5-yl)-2-(ethylamino)-1-pentanone (other
name: N-ethylpentylone);
3. 1-[1-(3-methoxyphenyl)cyclohexyl]piperidine (other name:
3-methoxy PCP);
4. 1-[1-(4-methoxyphenyl)cyclohexyl]piperidine (other name:
4-methoxy PCP);
5. 4-Chloroethcathinone (other name: 4-CEC);
6. 3-Methoxy-2-(methylamino)-1-(4-methylphenyl)-1-propanone
(other name: Mexedrone);
7. 3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methyl-benzamide
(other name: U-47700);
8. 3,4-dichloro-N-{[1-(dimethylamino)cyclohexyl]methyl}
benzamide (other name: AH-7921);
9. N-phenyl-N-[1-(2-phenylethyl)-4-piperidinyl]-pentanamide
(other name: Pentanoyl fentanyl);
10. N-phenyl-N-[1-(2-phenylethyl)-4-piperidinyl]-2-furancarboxamide
(other name: Furanyl fentanyl);
11.
N-(3-fluorophenyl)-N-[1-(2-phenethyl)-4-piperidinyl]-propanamide (other name:
3-fluorofentanyl);
12. Clonazolam; and
13. Cannabimimetic agents:
a. Methyl 2-({1-[(4-fluorophenyl)methyl]-1H-indazole-3-carbonyl}amino)-3-methylbutanoate
(other names: AMB-FUBINACA, FUB-AMB);
b. N-(adamantan-1-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide
(other name: FUB-AKB48);
c. N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide
(other name: 5F-AKB48);
d. Naphthalen-1-yl 1-pentyl-1H-indazole-3-carboxylate (other
name: SDB-005); and
e. N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)indole-3-carboxamide
(other name: AB-CHMICA).
The placement of drugs listed in this subsection shall remain
in effect until March 7, 2018, unless enacted into law in the Drug Control Act.
C. Pursuant to subsection D of § 54.1-3443 of the Code of
Virginia, the Board of Pharmacy places the following in Schedule I of the Drug
Control Act:
1. 1-propionyl lysergic acid diethylamide (other name:
1P-LSD);
2. (2-Methylaminopropyl)benzofuran (other name: MAPB);
3. Ethyl phenyl(piperidin-2-yl)acetate (other name:
Ethylphenidate);
4. 2-(3-fluorophenyl)-3-methylmorpholine (other name:
3-fluorophenmetrazine); and
5.
N-(4-fluorophenyl)-N-[1-(2-phenylethyl)-4-piperidinyl]-butanamide (other name:
para-fluorobutyrylfentanyl), its optical, positional, and geometric isomers,
salts and salts of isomers.
The placement of drugs listed in this subsection shall
remain in effect until May 10, 2018, unless enacted into law in the Drug
Control Act.
VA.R. Doc. No. R17-4746; Filed September 22, 2016, 3:10 p.m.